BOSTON — The Boston Life Sciences, Biotech, Pharma, and Medical Facilities Conference is set to be one of the most pivotal industry gatherings of the year. Organized by Boston Real Estate Times and Life Sciences Times, this exclusive event will take place on April 17, 2025, from 7:00 AM to 10:00 AM at the Burlington Marriott Hotel in Burlington, MA.
At a time when the Greater Boston life sciences real estate market faces unprecedented challenges, and biotech, pharma, and healthcare industries navigate critical transitions, this conference will bring together top-tier industry executives, developers, investors, and innovators to explore the future of these high-stakes sectors.
With an expertly curated panel of thought leaders, the event will provide unparalleled networking opportunities, market insights, and expert analysis on the evolving landscape of life sciences, biotech, and medical facility development.
A Powerful Speaker Lineup Featuring Industry Visionaries
The conference proudly announces its first set of distinguished speakers:
Purnanand Sarma, Ph.D.
CEO, Aro Biotherapeutics | Biotech Innovator & Strategic Leader
A transformative leader in drug development, Sarma has more than 30 years of experience in the pharmaceutical and biotech industries. As CEO of Aro Biotherapeutics, he is pioneering advancements in siRNA-based therapeutics, driving the company’s flagship ABX1100 drug for Pompe disease, and leading Aro through its next phase of growth.
His extensive experience includes successful IPOs, M&A transactions, and strategic asset development. Before Aro, he was the CEO of Immunome (NASDAQ: IMNM) and led TARIS Biomedical’s high-profile acquisition by Johnson & Johnson.
Dr. Sarma is also the President of TiE Boston, fostering entrepreneurship among emerging biotech founders. With a Ph.D. in Pharmaceutics from the University of Minnesota, his insights will be invaluable for attendees seeking a deeper understanding of biotech investment trends, drug development, and the future of precision medicine.
Robert (Bob) Doherty
Vice President of Development, Boston Development Group | Expert in Life Sciences Real Estate
A veteran in real estate development, leasing, and brokerage, Bob Doherty brings over 35 years of industry expertise. Currently, he is leading the development of a 50,000-square-foot, all-electric medical office building in Needham, MA, a first-of-its-kind project compliant with new Massachusetts Energy Codes.
His impressive career includes a tenure at Related Companies and international work with EMC, providing him with a global perspective on real estate innovation and sustainable development. Attendees will gain exclusive insights into how the Boston life sciences real estate market can adapt, recover, and thrive amid economic and policy shifts.
Gary Kaufman
COO, ABI-LAB | Angel Investor & Biotech Incubator Pioneer
A key figure in biotech incubation, Gary Kaufman has played a vital role in fostering early-stage biotech innovation. As COO of ABI-LAB, he is instrumental in nurturing emerging biotech startups and is currently developing an investment vehicle to fund 2–4 new biotech companies annually.
With over 30 years of entrepreneurial experience across biotech, real estate, and startup ecosystems, Kaufman also serves as President of Shelby Enterprises Inc. and Co-founder of the Metrowest Life Sciences Network, driving industry collaboration and regional biotech growth.
His session will offer unique investment perspectives, strategies for building successful biotech ventures, and insights into the next wave of life sciences innovation.
Jonathan Cocker
Principal, Maugel DeStefano Architects | Leader in Healthcare & Life Sciences Facility Design
A visionary in healthcare architecture, Jonathan Cocker will explore cutting-edge advancements in designing next-generation medical and life sciences facilities. His session will cover:
- Hospital navigation & patient-centered design
- Flexible & future-proof medical spaces
- Sustainable, all-electric healthcare buildings
- Technology integration in modern healthcare environments
As a principal at Maugel DeStefano Architects, Cocker leads the firm’s healthcare division, ensuring that facilities are not only state-of-the-art but also optimized for efficiency, patient care, and long-term adaptability.
Why You Can’t Afford to Miss This Conference
🔹 Unmatched Industry Expertise
Hear from top executives, investors, and developers who are actively shaping the future of biotech, pharma, and healthcare infrastructure.
🔹 Exclusive Market Insights
Gain data-driven analysis on the Boston life sciences real estate market, emerging biotech investment opportunities, and the impact of evolving healthcare policies.
🔹 Powerful Networking Opportunities
Connect with leading investors, CEOs, developers, architects, and policymakers in the life sciences, biotech, and medical real estate industries.
🔹 Timely Discussion on Market Challenges & Opportunities
With life sciences real estate facing headwinds and healthcare infrastructure remaining stable, experts will dissect:
✅ Will the Boston life sciences real estate market recover? If so, when?
✅ How are funding cuts and policy shifts reshaping biotech and pharma?
✅ What role will innovation play in revitalizing the industry?
Secure Your Spot Today!
🚀 Date: April 17, 2025
📍 Venue: Burlington Marriott Hotel, Burlington, MA
⏰ Time: 7:00 AM – 10:00 AM
💼 Who Should Attend?
✔️ Biotech & Pharma Executives
✔️ Real Estate Developers & Investors
✔️ Architects & Facility Designers
✔️ Healthcare Administrators
✔️ Policy Experts & Industry Analysts
This high-impact event is a must-attend for anyone invested in the future of biotech, life sciences real estate, and healthcare facilities. Don’t miss out—reserve your seat now!
📢 Click here to Register Today!
